" class="no-js "lang="en-US"> Ivan Jarry - Medtech Alert
Wednesday, May 31, 2023
Ivan Jarry

Ivan Jarry

About Ivan Jarry

I co-founded SPRIM, a global life sciences consultancy in 2001. We have since opened 18 offices worldwide, serving more than 450 clients, amongst them many of the largest multinationals in consumer health and pharma.

In 2015, we leveraged that experience to launch SPRIM Ventures, a venture capital company that builds and invests in early stage healthcare startups to bring innovation efficiently to scale. SPRIM’s Consulting and Ventures teams work synergistically to incubate ideas and translate them into faster, more cost effective solutions with the potential to improve health and quality of life for millions.

I am a proven leader that develops winning strategies and focuses organizations to achieve positive change based on well-developed customer and operational insights, strong analytical skills and the capacity to consistently build strong, enduring relationships with partners.

Related Story

ObvioHealth Announces Ground-Breaking Digital Therapeutics API to Capture More Accurate Efficacy and Adherence Data in Clinical Trials

February 22 2023

ObvioHealth, a pioneering virtual research organization, announces the launch of a proprietary application programming interface […]

ObvioHealth Introduces ObvioGo, a Next-Generation DCT Platform and Mobile Application Delivering Stronger Evidence

September 15 2022

ObvioHealth, a pioneering virtual research organization (VRO), announces the launch of ObvioGo, a next-generation decentralized […]

ObvioHealth Welcomes Scott Dixon as Newest Chief Commercial Officer

September 1 2022

ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott […]

ObvioHealth Expands Digital Health Research Ecosystem Through New Global Licensing Agreement With Dedalus

June 28 2022

ObvioHealth, a global virtual research organization (VRO), extends its strategic alliance with Dedalus Group (“Dedalus”), […]